Kevin J. McNamara net worth and biography

Kevin McNamara Biography and Net Worth

CEO, President & Director of Chemed

Kevin J. McNamara is President and Chief Executive Officer of Chemed Corporation (NYSE:CHE). He is also Chairman of the company's VITAS Healthcare Corporation subsidiary. Mr. McNamara began his career at Chemed in 1980 as a corporate attorney. In 1981, he moved to Omnicare, Inc. (NYSE:OCR), Chemed’s then 24%-owned affiliate, as Secretary. In 1986, Mr. McNamara returned to Chemed and was named Vice President, General Counsel, and Secretary. From 1990 through 1992, he also served as Executive Vice President and Chief Operating Officer of Omnicare. In 1992, Mr. McNamara was elected Vice Chairman of Chemed, while still serving as its General Counsel and Secretary. In 1993, he was named Executive Vice President, Secretary, and General Counsel of Chemed. The Board of Directors elected Mr. McNamara to his present position of President in 1994 and to the additional post of Chief Executive Officer in 2001. In February 2004, he also became Chairman of the company's VITAS subsidiary. Mr. McNamara holds an A.B. degree in economics from Denison University and a J.D. from Cornell Law School.

What is Kevin J. McNamara's net worth?: The estimated net worth of Kevin J. McNamara is at least $53.22 million as of November 25th, 2024. Mr. McNamara owns 101,735 shares of Chemed stock worth more than $53,223,683 as of December 21st. This net worth approximation does not reflect any other investments that Mr. McNamara may own. Additionally, Mr. McNamara receives a salary of $5,840,000.00 as CEO, President & Director at Chemed. Learn More about Kevin J. McNamara's net worth.
How old is Kevin J. McNamara?: Mr. McNamara is currently 70 years old. There are 5 older executives and no younger executives at Chemed. Learn More on Kevin J. McNamara's age.
What is Kevin J. McNamara's salary?: As the CEO, President & Director of Chemed Co., Mr. McNamara earns $5,840,000.00 per year. Learn More on Kevin J. McNamara's salary.
How do I contact Kevin J. McNamara?: The corporate mailing address for Mr. McNamara and other Chemed executives is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. Chemed can also be reached via phone at (513) 762-6690. Learn More on Kevin J. McNamara's contact information.
Has Kevin J. McNamara been buying or selling shares of Chemed?: Over the course of the past ninety days, Kevin J. McNamara has sold $1,145,540.00 in shares of Chemed stock. Most recently, Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $572.77, for a transaction totalling $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares of the company's stock, valued at $58,270,755.95. Learn More on Kevin J. McNamara's trading history.
Who are Chemed's active insiders?: Chemed's insider roster includes Patrick Grace (Director), Brian Judkins (VP), Spencer Lee (EVP), Kevin McNamara (CEO, President & Director), Thomas Rice (Director), Donald Saunders (Director), George Walsh, III (Director), Nicholas Westfall (EVP), Nicholas Westfall (EVP), David Williams (CFO), and Michael Witzeman (VP). Learn More on Chemed's active insiders.
Are insiders buying or selling shares of Chemed?: During the last twelve months, insiders at the sold shares 15 times. They sold a total of 33,468 shares worth more than $20,256,317.52. The most recent insider tranaction occured on November, 27th when EVP Spencer S Lee sold 732 shares worth more than $421,353.84. Insiders at Chemed own 3.3% of the company. Learn More about insider trades at Chemed.
Information on this page was last updated on 11/27/2024.

Kevin J. McNamara Insider Trading History at Chemed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/25/2024	Sell	2,000	$572.77	$1,145,540.00	101,735
9/26/2024	Sell	2,000	$598.81	$1,197,620.00	103,735
8/5/2024	Sell	2,000	$569.63	$1,139,260.00	105,735
6/6/2024	Sell	1,500	$544.17	$816,255.00	107,049
5/16/2024	Sell	4,000	$567.54	$2,270,160.00	108,549
12/11/2023	Sell	1,500	$572.77	$859,155.00	111,468
10/31/2023	Sell	5,000	$560.68	$2,803,400.00	112,968
8/3/2023	Sell	4,000	$516.43	$2,065,720.00	115,571
5/5/2023	Sell	4,000	$549.34	$2,197,360.00	119,571
3/28/2023	Sell	3,000	$526.27	$1,578,810.00	118,613
3/9/2023	Sell	2,000	$507.32	$1,014,640.00	121,613
11/21/2022	Sell	2,000	$505.76	$1,011,520.00	121,264
11/3/2022	Sell	2,000	$482.90	$965,800.00	122,235
9/13/2022	Sell	2,000	$474.13	$948,260.00	124,235
8/18/2022	Sell	3,000	$481.93	$1,445,790.00	125,185
5/10/2022	Sell	2,000	$502.00	$1,004,000.00	128,185
5/2/2022	Sell	3,000	$486.79	$1,460,370.00	128,048
3/8/2022	Sell	3,000	$469.91	$1,409,730.00
11/15/2021	Sell	3,000	$500.54	$1,501,620.00
11/2/2021	Sell	6,000	$485.06	$2,910,360.00
8/9/2021	Sell	3,000	$467.78	$1,403,340.00	128,688
6/4/2021	Sell	3,000	$497.61	$1,492,830.00	131,688
5/5/2021	Sell	3,000	$477.37	$1,432,110.00	140,497
1/8/2021	Sell	2,000	$549.30	$1,098,600.00	140,963
12/29/2020	Sell	2,500	$525.50	$1,313,750.00	130,963
11/9/2020	Sell	4,000	$485.13	$1,940,520.00	133,463
11/6/2020	Sell	4,500	$499.31	$2,246,895.00
8/4/2020	Sell	8,000	$500.39	$4,003,120.00	154,527
5/26/2020	Sell	5,000	$483.98	$2,419,900.00	138,727
5/13/2020	Sell	7,000	$431.36	$3,019,520.00	143,727
8/22/2019	Sell	5,000	$432.73	$2,163,650.00	134,712
8/7/2019	Sell	12,000	$416.80	$5,001,600.00	124,318
5/6/2019	Sell	6,000	$331.67	$1,990,020.00	159,334
3/22/2019	Sell	1,400	$324.52	$454,328.00
2/26/2019	Sell	5,000	$323.47	$1,617,350.00	155,094
11/9/2018	Sell	827	$315.74	$261,116.98	122,308
11/2/2018	Sell	7,000	$305.98	$2,141,860.00	141,293
8/23/2018	Sell	4,000	$319.50	$1,278,000.00	139,491
6/19/2018	Sell	19,000	$322.27	$6,123,130.00	124,491
5/9/2018	Sell	10,000	$319.22	$3,192,200.00	168,186
4/24/2018	Sell	22,000	$299.69	$6,593,180.00	185,375
3/1/2018	Sell	6,000	$258.00	$1,548,000.00	140,049
11/15/2017	Sell	5,000	$232.59	$1,162,950.00	136,800
10/31/2017	Sell	10,000	$223.42	$2,234,200.00	170,016
7/28/2017	Sell	15,000	$201.16	$3,017,400.00	173,801
5/2/2017	Sell	4,000	$205.11	$820,440.00	148,943
3/3/2017	Sell	7,000	$181.74	$1,272,180.00	149,191
2/24/2017	Sell	7,000	$177.63	$1,243,410.00	160,010
10/31/2016	Sell	10,000	$138.40	$1,384,000.00	189,266
8/3/2016	Sell	18,000	$144.87	$2,607,660.00	163,266
11/6/2015	Sell	6,000	$157.02	$942,120.00	167,736
10/26/2015	Sell	8,000	$149.04	$1,192,320.00	173,736
5/7/2015	Sell	8,000	$120.82	$966,560.00
2/20/2015	Sell	13,000	$112.71	$1,465,230.00
11/4/2014	Sell	4,000	$104.13	$416,520.00
8/7/2014	Sell	5,000	$100.05	$500,250.00
7/25/2014	Sell	10,000	$101.00	$1,010,000.00

Kevin J. McNamara Buying and Selling Activity at Chemed

Chemed Company Overview

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Today's Range

Now: $523.16

$520.00

$526.21

50 Day Range

MA: $564.38

$518.59

$612.59

2 Week Range

Now: $523.16

$516.91

$654.62

Volume

241,923 shs

Average Volume

87,427 shs

Market Capitalization

$7.87 billion

P/E Ratio

26.44

Dividend Yield

0.37%

Beta

0.46

This Crypto Is Set to Explode in December

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Kevin McNamara Biography and Net Worth

What is Kevin J. McNamara's net worth?

How old is Kevin J. McNamara?

What is Kevin J. McNamara's salary?

How do I contact Kevin J. McNamara?

Has Kevin J. McNamara been buying or selling shares of Chemed?

Who are Chemed's active insiders?

Are insiders buying or selling shares of Chemed?